Across TCGA pan-cancer cohorts, CD83P1 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated CD83P1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CD83P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CD83P1 expression acts as an unfavorable survival marker.

LUAD, ACC, and LIHC are the cancer types where CD83P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.644	0.824	<.001	111	view →
ACC	DFS	Tertile	All	0.137	0.771	<.001	72	view →
LIHC	DFS	Tertile	All	0.073	0.535	<.001	60	view →
STAD	DFS	Quartile	All	0.523	0.758	.002	54	view →
LUSC	OS	Tertile	III,IV	0.247	0.602	.003	42	view →
CESC	OS	Tertile	IV	0.164	0.612	.013	36	view →
COAD	OS	Tertile	IV	0.089	0.676	<.001	36	view →
KIRC	DFS	Quartile	III,IV	0.332	0.505	.017	30	view →
SKCM	DFS	Tertile	All	0.499	0.637	.001	21	view →
THCA	OS	Tertile	II,III,IV	0.150	0.902	.001	18	view →
THYM	DFS	Tertile	II,III,IV	0.172	0.745	.046	9	view →
SARC	DFS	Tertile	All	0.212	0.548	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

Exploration

Same gene, other analysis: CD83P1 tumor-vs-normal RNA expression · all CD83P1 data types